Search for: "Glaxosmithkline PLC" Results 121 - 140 of 203
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Apr 2010, 2:27 pm by Tom Lamb
In her April 28, 2010 piece, "Critics cite Avandia in pushing FDA safety reforms", Reuters reporter Lisa Richwine provided us the reactions of the FDA and Representative DeLauro to the this testimony by Senator Grassley in the context of the current debate about the safety of the diabetes drug Avandia: Two drug safety reviewers have recommended that [GlaxoSmithKline Plc diabetes drug Avandia] come off the market after concluding it was more dangerous to the heart than… [read post]
11 Apr 2010, 4:27 pm by Christopher T. Hurley
The drug, Avodart, manufactured by GlaxoSmithKline PLC us already used for urinary problems, thus far without any heart risk failure issues. [read post]
30 Mar 2010, 5:36 pm by Mark Zamora
Saudi Arabia has suspended GlaxoSmithKline PLC's (GSK) diabetes drug Avandia for six months, saying the product's heart risks outweigh its benefits, but the U.K. [read post]
26 Feb 2010, 12:26 am by Dr. Shezad Malik
GlaxoSmithKline Plc rejected allegations that it concealed safety information about its diabetes drug Avandia or acted inappropriately in marketing it, saying a U.S. [read post]
23 Feb 2010, 12:46 am by Dr. Shezad Malik
The Food and Drug Administration, under fire from a new Senate report questioning the safety of GlaxoSmithKline PLC's diabetes drug Avandia, told doctors that patients taking the medicine should stay on it unless their doctors say otherwise. [read post]
18 Feb 2010, 6:10 pm by Lebowitz & Mzhen
GlaxoSmithKline PLC says it is taking “voluntary, precautionary” measures by removing zinc from all of its denture creams. [read post]
15 Dec 2009, 11:32 pm by Dr. Shezad Malik
GlaxoSmithKline Plc has paid almost $1 billion to resolve lawsuits over Paxil since it introduced the antidepressant in 1993, including about $390 million for suicides or attempted suicides said to be linked to the drug, according to court records and people familiar with the cases. [read post]
13 Nov 2009, 11:52 am
Tafas and GlaxoSmithKline moot due to the fact that USPTO Director David Kappos has withdrawn the rules. [read post]
21 Oct 2009, 7:05 am by Greenberg & Rudman
The parent company that creates the drug Paxil, GlaxoSmithKline Plc, was ordered to pay $2.5 million in a lawsuit that claimed that the drug caused birth defects. [read post]
19 Oct 2009, 5:53 pm
  It is impossible not to recognize the new [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group… [read post]
17 Oct 2009, 2:12 pm
 GlaxoSmithKline PLC’s Cervarix vaccine was approved for use in girls and women ages 10 to 25 …  While Cervarix, like Gardasil, protects against two HPV strains that are linked to about 70% of cervical-cancer cases in the U.S., the Cervarix vaccine doesn’t offer protection against the HPV strains that can cause genital warts. [read post]
14 Oct 2009, 12:03 pm
The US Drug Watchdog Expands its National Consumer Alert on the Denture Creams Super Poligrip and Fixodent, PR Web, October 14, 2009 Fixodent and Super PoliGrip Lawsuits Mount Over Denture Cream Poisoning, About Lawsuits, October 1, 2009 Related Web Resources: Fixodent, Proctor and Gamble GlaxoSmithKline, PLC US Drug Watchdog [read post]
13 Oct 2009, 3:29 pm
GlaxoSmithKline Plc must pay $2.5 M over claims that its Paxil antidepressant caused birth defects, a Pennsylvania jury concluded in the first of 600 such cases to come to trial. [read post]
13 Oct 2009, 2:24 am
GlaxoSmithKline Plc officials intentionally ignored the possibility that the Paxil antidepressant caused birth defects, a lawyer said in closing arguments of a trial over the drug. [read post]
9 Oct 2009, 12:15 pm
In an article titled New Chief of Patent Office Takes Aim at a Massive Backlog , AMY SCHATZ writes:U.K. drug maker GlaxoSmithKline PLC challenged the Bush administration's rules in federal court in 2007. [read post]
9 Oct 2009, 11:50 am
In his remarks before thousands of employees on the USPTO campus, Secretary Locke said "David is taking on a big job… Promoting and protecting U.S. [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007… [read post]
8 Oct 2009, 1:56 pm
PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. [read post]
8 Oct 2009, 12:27 am
GlaxoSmithKline Plc, the U.K.'s largest drugmaker, complied with all U.S. [read post]
1 Oct 2009, 2:14 am
GlaxoSmithKline PLC, 2008 WL 2247067 (E.D. [read post]